Stocks:
5,168
ETFs:
2,288
Exchanges:
11
Market Cap:
$64.20T
24h Vol:
$8.52B
Dominance:
MSFT:4.79%
Stocklytics Platform
Instrument logo  SYK
Stryker
SYK
68 / 100
S&P500
$330.57arrow_drop_down0.08%-$0.28

Performance History

Stocklytics logo
Key Stats
Open$331.79
Prev. Close$330.85
EPS8.77
Dividend$3.15
Next Earnings DateJul 29, 2024
Dividend Yield %0.96%
Market Cap$125.12B
PE Ratio37.69
LOWHIGH
Day Range330.14
332.82
52 Week Range249.98
361.41
Ratios
P/B Ratio7.00
Revenue$20.49B
Operating M. %18.56%
Earnings$3.16B
Earnings Growth %34.22%
EBITDA Margin %26.53%
ROE %18.64%
EPS8.77

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

68vs 56. Market Avg.

All Score 68 / 100 is to help users identify stocks that trade at a low value relative to their fundamentals. Suitable for value investors such as Warren Buffet.

SYKMARKET
Value2838
Quality7440
Ownership3617
Growth5546
Dividends2737
check_circle

Stryker's Price growth average in the last 3 years of 9.8% is great compared to market average of 7.76%. This indicates SYK could be a good value stock.

Financial Forecast

AI Price Prediction

line chart placeholder

Analyst Ratings

info
Analyst ratings for this stock instrument are based on analysts' assumptions and should not be solely relied upon for financial decisions.

Correlated Companies

PRICE$760.00
24H (%)arrow_drop_down1.49%
24H ($)-$11.54
MARKET CAP$739.19B
PRICE$512.81
24H (%)arrow_drop_up1.13%
24H ($)$5.78
MARKET CAP$453.09B
PRICE$149.91
24H (%)arrow_drop_up0.04%
24H ($)$0.06
MARKET CAP$357.92B
PRICE$130.06
24H (%)arrow_drop_down0.13%
24H ($)-$0.17
MARKET CAP$322.98B

About Stryker (SYK)

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.

Sector
Healthcare
Industry
Medical Devices
CEO
Mr. Kevin A. Lobo
Headquarters
Kalamazoo
Employees
51000
Exchange
NYSE
add Stryker to watchlist

Keep an eye on Stryker

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help
What is Stryker's (SYK) price per share?

The current price per share for Stryker (SYK) is $330.58. The stock has seen a price change of -$0.28 recently, indicating a -0.08% change. This reflects the stock's recent market performance and investor sentiment.

help
What is the 52-week high and low for Stryker (SYK)?

For Stryker (SYK), the 52-week high is $361.41, which is 9.33% from the current price. The 52-week low is $249.98, the current price is 32.24% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help
Is Stryker (SYK) a growth stock?

Stryker (SYK) has shown an average price growth of 0.41% over the past three years. It has received a score of 71 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Stryker as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help
What is Stryker (SYK) stock price performance year to date (YTD)?

As of the latest data, Stryker (SYK) has a year-to-date price change of 11.6%. Over the past month, the stock has experienced a price change of -4.54%. Over the last three months, the change has been -3.08%. Over the past six months, the figure is 17.29%. Looking at a longer horizon, the five-year price change stands at 79.47%.

help
Is Stryker (SYK) a profitable company?

Stryker (SYK) has a net income of $3.16B, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 63.7% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 18.56% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $20.5B, with a revenue growth rate of 11.11%, providing insight into the company's sales performance and growth. The gross profit is $13.06B. Operating income is noted at $3.89B. Furthermore, the EBITDA is $5.19B.

help
What is the market capitalization of Stryker (SYK)?

Stryker (SYK) has a market capitalization of $125.12B. The average daily trading volume is 1.67M, indicating the stock's liquidity and investor engagement.

News

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Approach investments with caution like a driver who slows down on a curvy road.